This inventor holds 1 USPTO granted patent. Top assignee: Sciclone Pharmaceuticals, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovations in Hepatitis B Treatment by Ying-Kit Leung
Introduction
Ying-Kit Leung is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis B infection. His innovative approach combines various antiviral agents to enhance treatment efficacy.
Latest Patents
Ying-Kit Leung holds a patent for a method of treating hepatitis B virus (HBV) infection. The patent, titled "Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir," describes a drug regimen that includes an antiviral-effective amount of thymosin alpha 1 (Tα1) and lamivudine, with the option of adding famciclovir. This combination aims to provide a more effective treatment for patients suffering from HBV infection.
Career Highlights
Ying-Kit Leung is associated with Sciclone Pharmaceuticals, Inc., where he continues to work on innovative solutions for viral infections. His research and development efforts focus on improving patient outcomes through advanced therapeutic strategies.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Ying-Kit Leung's work in the field of hepatitis B treatment exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for more effective therapies for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile